Literature DB >> 30635705

[Differential diagnosis of hypereosinophilia].

J C Henes1,2, S Wirths3, B Hellmich4.   

Abstract

Eosinophilia is defined as an elevated absolute number of eosinophilic leukocytes in peripheral blood or tissue. Its absolute number also defines the grade of eosinophilia. The main causes are allergic (including drug side effects) and infectious triggers but malignant and autoimmune diseases can also result in eosinophilia. Severe eosinophilia with the number of eosinophils >5000/µl are mostly caused by myeloproliferative disorders, eosinophilic granulomatosis with polyangiitis or during tissue migration in parasitic tissue infections. Hypereosinophilic syndrome is defined as eosinophilia with >1500 eosinophils/µl and a duration of more than 6 months by exclusion of parasitic infections, allergies or other causes of tissue eosinophilia with end-organ damage. For the diagnosis of a persistent eosinophilia a detailed medical history and physical examination should be followed by early organ screening, infection diagnostics especially for helminth infections and hematological laboratory analyses including bone marrow investigations.

Entities:  

Keywords:  Autoimmune diseases; Helminth infection; Hypereosinophilic syndrome; Malignancy; Organ screening

Mesh:

Year:  2019        PMID: 30635705     DOI: 10.1007/s00393-018-0587-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.530


  25 in total

Review 1.  [Hypereosinophilic syndrome--recent developments in diagnosis and treatment].

Authors:  B Hellmich; K Holl-Ulrich; W L Gross
Journal:  Dtsch Med Wochenschr       Date:  2007-09       Impact factor: 0.628

Review 2.  Eosinophilia.

Authors:  M E Rothenberg
Journal:  N Engl J Med       Date:  1998-05-28       Impact factor: 91.245

Review 3.  Eosinophilia: secondary, clonal and idiopathic.

Authors:  Ayalew Tefferi; Mrinal M Patnaik; Animesh Pardanani
Journal:  Br J Haematol       Date:  2006-06       Impact factor: 6.998

4.  Acute strongyloidiasis in a traveller returning from South East Asia.

Authors:  Kerstin Kling; Esther Kuenzli; Johannes Blum; Andreas Neumayr
Journal:  Travel Med Infect Dis       Date:  2016-05-15       Impact factor: 6.211

5.  Idiopathic hypereosinophilic syndrome in a 5 1/2-month-old infant.

Authors:  S R Wynn; M I Sachs; M U Keating; N K Ostrom; R P Kadota; E J O'Connell; W A Smithson
Journal:  J Pediatr       Date:  1987-07       Impact factor: 4.406

Review 6.  DRESS syndrome: a detailed insight.

Authors:  Sapan Kumar Behera; Saibal Das; Alphienes Stanley Xavier; Sandhiya Selvarajan
Journal:  Hosp Pract (1995)       Date:  2018-03-15

7.  FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature.

Authors:  A Pardanani; R P Ketterling; C-Y Li; M M Patnaik; A P Wolanskyj; M A Elliott; J K Camoriano; J H Butterfield; G W Dewald; A Tefferi
Journal:  Leuk Res       Date:  2006-01-06       Impact factor: 3.156

8.  Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia.

Authors:  H U Simon; S G Plötz; R Dummer; K Blaser
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

9.  Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection.

Authors:  M H Kaplan; W W Hall; M Susin; S Pahwa; S Z Salahuddin; C Heilman; J Fetten; M Coronesi; B F Farber; S Smith
Journal:  Am J Med       Date:  1991-09       Impact factor: 4.965

10.  The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.

Authors:  Guillaume Lefèvre; Marie-Christine Copin; Delphine Staumont-Sallé; Martine Avenel-Audran; Hélène Aubert; Alain Taieb; Gilles Salles; Hervé Maisonneuve; Kamel Ghomari; Félix Ackerman; Fanny Legrand; André Baruchel; David Launay; Louis Terriou; Christian Leclech; Chahera Khouatra; Chafika Morati-Hafsaoui; Myriam Labalette; Raphäel Borie; François Cotton; Noémie Le Gouellec; Franck Morschhauser; Jacques Trauet; Catherine Roche-Lestienne; Monique Capron; Pierre-Yves Hatron; Lionel Prin; Jean-Emmanuel Kahn
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

View more
  1 in total

Review 1.  [Eosinophilic granulomatosis with polyangiitis : Update on classification and management].

Authors:  Bernhard Hellmich; Julia Holle; Frank Moosig
Journal:  Z Rheumatol       Date:  2022-01-24       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.